Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing

15 Feb 2021

Abstract excerpt

Given the severity of the SARS-CoV-2 pandemic, a major challenge is to rapidly repurpose existing approved drugs for clinical interventions. While a number of data-driven and experimental approaches have been suggested in the context of drug repurposing, a platform that systematically integrates available transcriptomic, proteomic and structural data is missing. More importantly, given that SARS-CoV-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33589624
DOI: 10.1038/s41467-021-21056-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposingPMID 33589624Read ↗

Cumulative effect of aging and SARS-CoV2 infection on poor prognosis in the elderly: Insights from transcriptomic analysis of lung and bloodSemantic proximity Read ↗

The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2Semantic proximity Read ↗

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposingSemantic proximity Read ↗

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalSemantic proximity Read ↗

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalSemantic proximity Read ↗

Identification and Targeting of Regulators of SARS-CoV-2-Host Interactions in the Airway EpitheliumSemantic proximity Read ↗

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read ↗

Mechanistic modeling of the SARS-CoV-2 disease mapSemantic proximity Read ↗

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read ↗

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoVSemantic proximity Read ↗

The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2Semantic proximity Read ↗

The network of SARS-CoV-2—cancer molecular interactions and pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.